Cross Country Healthcare (CCRN) EBIT: 2009-2025
Historic EBIT for Cross Country Healthcare (CCRN) over the last 17 years, with Q3 2025 value amounting to -$6.0 million.
- Cross Country Healthcare's EBIT fell 30935.86% to -$6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$16.2 million, marking a year-over-year decrease of 20292500.0%. This contributed to the annual value of -$16.9 million for FY2024, which is 11496.28% down from last year.
- Per Cross Country Healthcare's latest filing, its EBIT stood at -$6.0 million for Q3 2025, which was down 30935.86% from -$5.9 million recorded in Q2 2025.
- In the past 5 years, Cross Country Healthcare's EBIT ranged from a high of $90.6 million in Q1 2022 and a low of -$19.2 million during Q2 2024
- For the 5-year period, Cross Country Healthcare's EBIT averaged around $25.9 million, with its median value being $20.3 million (2023).
- Its EBIT has fluctuated over the past 5 years, first skyrocketed by 704146.98% in 2021, then plummeted by 30935.86% in 2025.
- Quarter analysis of 5 years shows Cross Country Healthcare's EBIT stood at $76.0 million in 2021, then plummeted by 36.5% to $48.2 million in 2022, then plummeted by 72.17% to $13.4 million in 2023, then tumbled by 125.57% to -$3.4 million in 2024, then crashed by 73.99% to -$6.0 million in 2025.
- Its EBIT was -$6.0 million in Q3 2025, compared to -$5.9 million in Q2 2025 and -$977000.0 in Q1 2025.